Development of Direct LDL Measurement by LDL Precipitation Combined with Sandwich ELISA Using In-House-Generated mAbs.

One of the major risk factors for the progression of cardiovascular diseases is a high blood level of low-density lipoprotein (LDL), so progression of the disease may be prevented by lowering the plasma LDL. Evaluation and monitoring of LDL concentrations are therefore necessary. Friedewald's equation is a calculation method that is currently used routinely to estimate plasma LDL concentrations in hospital laboratories. However, this method cannot be applied to samples with a high concentration of triglyceride (TG). To overcome this limitation, this study aimed to develop direct LDL measurements using in-house generated monoclonal antibodies against human LDL in combination with LDL precipitation using heparin-containing citrate buffer pH 5.04. The method was applied to measure the LDL concentration in 208 randomized samples from Suranaree University of Technology Hospital. The mean values obtained from the developed method and the hospital laboratory were 126.6 ± 43.1 mg/dL and 123.2 ± 42.3 mg/dL, respectively. Linear regression analysis showed a high correlation between these two methods (r = 0.8491, p < 0.0001). High concentrations of TG, total cholesterol, and HDL have no influence on the LDL values obtained by this method. In this study, we offer an alternative technique for the direct measurement of plasma LDL. Further development for more convenient and easy use can now be undertaken.

[1]  Woochang Lee,et al.  Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol , 2022, Annals of laboratory medicine.

[2]  P. Khunkaewla,et al.  Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies. , 2021, Analytical biochemistry.

[3]  A. Jaffe,et al.  A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. , 2020, JAMA cardiology.

[4]  R. Krauss,et al.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel , 2020, European heart journal.

[5]  P. K. Sharma,et al.  Atherosclerosis. , 2020, The Journal of the Association of Physicians of India.

[6]  K. Sung,et al.  Comparison of Low-Density Lipoprotein Cholesterol Concentrations by Direct Measurement and by Friedewald Calculation. , 2019, The American journal of cardiology.

[7]  K. Saku,et al.  Comparison of Two Homogeneous LDL-Cholesterol Assays Using Fresh Hypertriglyceridemic Serum and Quantitative Ultracentrifugation Fractions , 2019, Journal of atherosclerosis and thrombosis.

[8]  A. Orekhov.  LDL and foam cell formation as the basis of atherogenesis , 2018, Current opinion in lipidology.

[9]  M. Blaha,et al.  Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. , 2013, JAMA.

[10]  P. Joshi,et al.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. , 2013, Journal of the American College of Cardiology.

[11]  A. Ogawa,et al.  Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[12]  Nader Rifai,et al.  Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. , 2002, Clinical chemistry.

[13]  M. Elisaf,et al.  Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. , 2000, Clinical biochemistry.

[14]  M. Esteban-Salán,et al.  Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in hyperlipidemic patients. , 2000, Clinical chemistry.

[15]  K. Uekama,et al.  Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate. , 1998, Clinical chemistry.

[16]  A. Maitra,et al.  Comparison of two assays for measuring LDL cholesterol. , 1997, Clinical chemistry.

[17]  I. Jialal.  A practical approach to the laboratory diagnosis of dyslipidemia. , 1996, American journal of clinical pathology.

[18]  P. Bachorik,et al.  National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. , 1995, Clinical chemistry.

[19]  C. A. Ferguson,et al.  Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. , 1995, Clinical chemistry.

[20]  L. Kerscher,et al.  Precipitation methods for the determination of LDL-cholesterol. , 1985, Clinical biochemistry.

[21]  P. Demacker,et al.  Five methods for determining low-density lipoprotein cholesterol compared. , 1984, Clinical chemistry.

[22]  N. Miller.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments. , 1979, Journal of clinical pathology.

[23]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[24]  S. Grundy,et al.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[25]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[26]  J. McNamara,et al.  Measurement of low-density-lipoprotein cholesterol in serum: a status report. , 1992, Clinical chemistry.

[27]  G. R. Warnick,et al.  Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. , 1990, Clinical chemistry.